Reappraisal of Peritoneal Washing Cytology in 984 Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Margin-Negative Resection
- 15 October 2014
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 19 (1) , 6-14
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine, 2013
- Incidence, Prognosis, and Possible Treatment Strategies of Peritoneal Carcinomatosis of Pancreatic OriginPancreas, 2013
- The Implications of Positive Peritoneal Lavage Cytology in Potentially Resectable Pancreatic CancerWorld Journal of Surgery, 2012
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancerThe American Journal of Surgery, 2010
- Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasisAnnals of Oncology, 2009
- 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal CancerAnnals of Surgical Oncology, 2008
- Clinical Implications of Peritoneal Cytology in Potentially Resectable Pancreatic CancerAnnals of Surgery, 2007
- The Influence of Positive Peritoneal Cytology on Survival in Patients With Pancreatic AdenocarcinomaJournal of Gastrointestinal Surgery, 2006
- EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancerInternational Journal of Oncology, 2005